Here are some key long-term side effects associated with semaglutide: Gallbladder problems : Increased risk of gallstones and gallbladder inflammation, leading to abdominal pain, fever, nausea, and vomiting
In a 68-week clinical trial, participants receiving semaglutide experienced an average body-weight reduction of 14.9% from baseline
The GIP receptor appears to enhance the appetite-suppressing effects of GLP-1 signaling and may have additional benefits for fat metabolism
Interacting medications and heat sensitivity If you are combining semaglutide with other medications, temperature damage to any one of them can affect your overall protocol
Guidelines recommended stopping semaglutide at least two months before planning pregnancy
Safety and Long-Term Use GLP-1 medications have been used for diabetes for over a decade, with extensive safety data